Form 4: Molina Healthcare Director Receives Equity Award
Statement of Changes in Beneficial Ownership
Richard C. Zoretic, a Director at Molina Healthcare, Inc., was granted 237 shares of common stock on July 1, 2026, as part of his annual equity award.
Summary
- Richard C. Zoretic, a Director of Molina Healthcare, Inc. (MOH), received a grant of 237 shares of common stock on July 1, 2026.
- This grant is part of the Issuer's 2025 Equity Incentive Plan, awarded in connection with Zoretic's services as a Director.
- The annual equity award for directors is valued at $220,000, with one-quarter ($55,000) granted on the first day of each quarter.
- The number of shares granted is based on the closing price of the Issuer's common stock on the grant date.
- On July 1, 2026, the closing price was $232.55 per share, resulting in the grant of 237 shares.
- The shares are beneficially owned indirectly through the Richard Charles Zoretic Revocable Living Trust.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it reports a routine equity grant to a director as part of an established compensation plan, with no significant new information or strategic shifts.
Positives
- Director compensation aligns with company stock performance through equity grants.
- Annual equity awards demonstrate a commitment to retaining and incentivizing directors.
- The grant is part of a structured incentive plan, indicating a well-defined compensation strategy.
Future Outlook
The filing does not contain forward-looking statements or guidance. It reports a completed transaction.
Industry Context
StockSavvy.ai notes that equity awards to directors are a common practice in the healthcare and managed care industry to align executive and director interests with those of shareholders and to attract and retain talent.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Power of Attorney | Richard C. Zoretic granted a Limited Power of Attorney to Jeff D. Barlow and Codruta Boggs to execute Section 16(a) filings on his behalf. | 05/14/2018 | Facilitates timely and accurate filing of required SEC disclosures by authorized representatives. |
Related Party Transactions
- Grant of stock under the Issuer's 2025 Equity Incentive Plan to Director Richard C. Zoretic.
Stakeholder Impact
- Shareholders: The equity grant aligns director compensation with company performance, potentially benefiting shareholders through motivated leadership.
- Employees: The incentive plan structure may indirectly influence employee morale and retention if perceived as fair and effective.
- Management: The filing confirms the ongoing compensation practices for directors.
Key Dates
| Date | Description |
|---|---|
| 05/14/2018 | Date of execution for the Limited Power of Attorney for Section 16(a) Filings by Richard Zoretic. |
| 07/01/2026 | Transaction date for the grant of common stock to Richard C. Zoretic. |
| 07/02/2026 | Date of signature for the Form 4 filing. |
Keywords
Molina Healthcare, MOH, Form 4, SEC Filing, Director Compensation, Equity Award, Stock Grant, Beneficial Ownership, Richard C. Zoretic, 2025 Equity Incentive Plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.